Combidex USPIO - Ultra-small Superparamagnetic Iron Oxide

Clinical trial NCT00188695 · COMPLETED

Trial details

NCT number: NCT00188695
Sponsor: University Health Network, Toronto
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Uterine Neoplasms Cervix Neoplasms Bladder Neoplasms Prostatic Neoplasms

Start date: 2004-04-01
Primary completion: 2006-06-01
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.